期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Bezafibrate对大鼠高脂血症和脂肪肝形成的影响 被引量:29
1
作者 范建高 曾民德 +3 位作者 李继强 邱德凯 李超群 李蓉蓉 《胃肠病学和肝病学杂志》 CAS 1999年第2期100-102,共3页
目的探讨以降低甘油三酯为主的血脂调整药对高脂血症脂肪肝的防治作用。方法观察Bezafibrate对高脂饮食诱发Wistar大鼠高脂血症和脂肪肝形成的影响(治疗组,n=8),并设模型组和正常饮食组作对照。结果与正常组相... 目的探讨以降低甘油三酯为主的血脂调整药对高脂血症脂肪肝的防治作用。方法观察Bezafibrate对高脂饮食诱发Wistar大鼠高脂血症和脂肪肝形成的影响(治疗组,n=8),并设模型组和正常饮食组作对照。结果与正常组相比,模型组血脂和肝匀浆脂肪含量均显著升高,肝组织学呈中至重度脂肪变。与模型组相比,治疗组血清甘油三酯和总胆固醇显著下降,但血清转氨酶和肝匀浆脂质含量却呈升高趋势,肝脏病理学变化与模型组基本相近。结论Bezafibrate虽可显著降低高脂饮食诱发的高脂血症,但对肝内脂肪沉积并无防治作用。 展开更多
关键词 bezafibrate 高脂血症 脂肪肝 血脂调整药
下载PDF
Effect of effluent organic matter on ozonation of bezafibrate
2
作者 Huan HE Qian SUI +3 位作者 Shuguang LU Wentao ZHAO Zhaofu QIU Gang YU 《Frontiers of Environmental Science & Engineering》 SCIE EI CAS CSCD 2015年第6期962-969,共8页
The influence of three effluent organic matter (EfOM) model compounds, humic acid (HA), bovine serum albumin (BSA), and sodium alginate (AGS), on the ozonation ofbezafibrate (BF), a typical pharmaceutical an... The influence of three effluent organic matter (EfOM) model compounds, humic acid (HA), bovine serum albumin (BSA), and sodium alginate (AGS), on the ozonation ofbezafibrate (BF), a typical pharmaceutical and personal care product (PPCP), was investigated. The results show that ozonation efficiently removed BF from aqueous solution with removal efficiencies 〉 95% within 8 min for all conditions. The reaction rate of BF decreased with increasing model compounds concentrations and the influence was more pronounced for HA and BSA, while less pronounced for AGS. Although BF concentration was significantly reduced, the degree of mineralization achieved was only approximately 11%. The addition of HA and BSA improved the mineralization of the solution, while the influence of AGS was minor. The acute toxicity of BF solution during ozonation was determined using the Luminescent bacteria test, and the toxicity exhibited an initial increase and a successive reduction. An overall decreased acute toxicity was observed with an increase of HA. The presence of BSA increased the formation rate of toxicity intermediates and resulted in inhibition peak forward. 展开更多
关键词 OZONATION bezafibrate acute toxicity humicacid bovine serum albumin sodium alginate
原文传递
Spontaneous regression of hepatic inflammatory pseudotumor with primary biliary cirrhosis:Case report and literature review 被引量:13
3
作者 Hiroshi Koide Ken Sato +8 位作者 Toshio Fukusato Kenji Kashiwabara Noriaki Sunaga Takafumi Tsuchiya Saeko Morino Naondo Sohara Satoru Kakizaki Hitoshi Takagi Masatomo Mori 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第10期1645-1648,共4页
Hepatic inflammatory pseudotumor (IPT) is a rare benign non-neoplastic lesion characterized by proliferating fibrous tissue infiltrated by inflammatory cells. The exact etiology of IPT remains unclear. Although the ... Hepatic inflammatory pseudotumor (IPT) is a rare benign non-neoplastic lesion characterized by proliferating fibrous tissue infiltrated by inflammatory cells. The exact etiology of IPT remains unclear. Although the association of IPT with systemic inflammatory disorders has been well established, a specific relationship with cholangitis is distinctly rare. We report a case of spontaneous regression of hepatic IPT with primary biliary cirrhosis (PBC). To date, only two cases of IPT with PBC have been reported. In our case, however, IPT developed during the course of improvement of cholangitis of PBC induced by effective treatment, differing from two previously reported cases. Our case indicates that the development of IPT does not also relate to the activity of cholangitis and/or hyper gamma-globulinemia, since our case was confirmed radiologically to be free of IPT when biliary enzymes and immunoglobulins were much higher than the corresponding values on admission. Comparison of our case with the two previously reported cases suggests that IPT occurring with PBC does not represent the same disease entity or be a bystander for PBC. 展开更多
关键词 Hepatic inflammatory pseudotumor Primary biliary cirrhosis Spontaneous regression Ursodeoxycholic acid bezafibrate
下载PDF
HBXIP blocks myosin-ⅡA assembly by phosphorylating and interacting with NMHC-ⅡA in breast cancer metastasis
4
作者 Lu Zhang Xiaolei Zhou +11 位作者 Bowen Liu Xuhe Shi Xianmeng Li Feifei Xu Xueli Fu Xue Wang Kai Ye Tianzhi Jin Huimin Sun Qianqian Li Weiying Zhang Lihong Ye 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2023年第3期1053-1070,共18页
Tumor metastasis depends on the dynamic balance of the actomyosin cytoskeleton.As a key component of actomyosin filaments,non-muscle myosin-ⅡA disassembly contributes to tumor cell spreading and migration.However,its... Tumor metastasis depends on the dynamic balance of the actomyosin cytoskeleton.As a key component of actomyosin filaments,non-muscle myosin-ⅡA disassembly contributes to tumor cell spreading and migration.However,its regulatory mechanism in tumor migration and invasion is poorly understood.Here,we found that oncoprotein hepatitis B X-interacting protein(HBXIP) blocked the myosin-ⅡA assemble state promoting breast cancer cell migration.Mechanistically,mass spectrometry analysis,co-immunoprecipitation assay and GST-pull down assay proved that HBXIP directly interacted with the assembly-competent domain(ACD) of non-muscle heavy chain myosin-ⅡA(NMHC-ⅡA).The interaction was enhanced by NMHC-ⅡA S1916 phosphorylation via HBXIP-recruited protein kinase PKCβⅡ.Moreover,HBXIP induced the transcription of PRKCB,encoding PKCβⅡ,by coactivating Sp1,and triggered PKCβⅡ kinase activity.Interestingly,RNA sequencing and mouse metastasis model indicated that the anti-hyperlipidemic drug bezafibrate(BZF) suppressed breast cancer metastasis via inhibiting PKCβⅡ-mediated NMHC-ⅡA phosphorylation in vitro and in vivo.We reveal a novel mechanism by which HBXIP promotes myosin-ⅡA disassembly via interacting and phosphorylating NMHC-ⅡA,and BZF can serve as an effective anti-metastatic drug in breast cancer. 展开更多
关键词 Breast cancer metastasis Actomyosin cytoskeleton HBXIP Myosin-IIA NMHC-IIA PHOSPHORYLATION PKCβII bezafibrate
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部